Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Fonte Standard Gras
Identifiant

Unité de recherche

INNOSUISSE

Numéro de projet

7505.1;6 DCPP-LS

Titre du projet

Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Titre du projet anglais

Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Textes relatifs à ce projet

	Allemand	Français	Italien	Anglais
Description succincte	-	-	-
Résumé des résultats (Abstract)	-	-	-

Textes saisis

Catégorie	Texte
Description succincte (Anglais)	Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy
Résumé des résultats (Abstract) (Anglais)	We developed a novel class of receptor proteins, Designed Repeat Proteins (DRPs), with an extraordinary potential to complement and substitute classical antibodies in biotechnological, diagnostic and therapeutic applications. DRPs possess affinities and specificities of antibodies, but surpass them in expression yield, stability and intracellular efficacy. The aim of this KTI-Discovery project is now to develop a range of commercial applications based on the DRP technology.

Catégorie

Texte

Description succincte
(Anglais)

Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Résumé des résultats (Abstract)
(Anglais)

We developed a novel class of receptor proteins, Designed Repeat Proteins (DRPs), with an extraordinary potential to complement and substitute classical antibodies in biotechnological, diagnostic and therapeutic applications. DRPs possess affinities and specificities of antibodies, but surpass them in expression yield, stability and intracellular efficacy. The aim of this KTI-Discovery project is now to develop a range of commercial applications based on the DRP technology.